Clinical Trials in New York

Showing 19221-19240 of 22,668 trials

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

NCT00291187

The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

Insomnia

Vanda Pharmaceuticals411 participantsStarted Feb 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +16 more locations

COMPLETEDPhase 3< 1 mile

Weight Loss Study for People With Type 2 Diabetes

NCT01601574

The purpose of this study is to determine whether the Weight Watchers program modified for use by people with Type 2 diabetes results in more improvements in blood glucose control relative to a control group receiving standard diabetes counseling.

Type 2 DiabetesOverweightObesity

Medical University of South Carolina563 participantsStarted May 2012

Birmingham, Alabama, United States • La Jolla, California, United States • Augusta, Georgia, United States +12 more locations

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

Weight Loss Study for People With Type 2 Diabetes

Find Trials by Condition in New York

VEC-162 Study in Adult Patients With Primary Insomnia

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

Experimental Medication For the Treatment of Generalized Anxiety Disorder

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Safety and Effectiveness of JUVÉDERM™ Injectable Gel With Lidocaine

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

HMO Research Network CERT: Acute Myocardial Infarction

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach